Eurofins announces acquisition of Bio-Access
The company said it shares controlling stock of Bio-Access' founder Jean-Louis Oger and current leadership. The acquired company employs approximately 1,100 people. and focuses in medical and biological research in facilities throughout France.
Eurofins has anticipated that the company will generate revenues of approximately $153 million.
Shareholders of Bio-Access are working with the company on additional agreements relating to future investments into the company that will ultimately end up as liquidity for the stakes of the founder and other members of leadership provided by Eurofins.
Eurofins is a global group that offers laboratory and testing services to multiple sectors and industries including genomics, agricultural science, pharmacology, central laboratory services, and food and pharmaceutical products. Approximately 17,000 people are employed by Eurofins in laboratory facilities across 38 countries.